Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acquiree, adventure, affirmative, affirming, aforementioned, Alexion, allergic, allogeneic, amplification, anemia, Annex, Argenx, argument, Armory, assembled, AstraZeneca, attack, autoantibody, BCMA, benchmark, benchmarked, Biden, Bio, Biogen, booked, bridge, businesspeople, Cabaletta, Canadian, capped, CAR, cartesian, cascade, CBER, ceiling, Century, certify, Chase, chemotherapy, chewing, chimeric, chose, Clawback, CMS, colorable, combat, complement, cord, COSO, crossover, customarily, cutoff, CVR, cyclophosphamide, cytokine, daughter, Deadline, dedicated, deep, deepened, deferral, deliverable, DGCL, disaggregated, disaggregation, dispute, dissolution, distinguished, Distinguishing, division, donut, East, embodied, encoding, enjoining, excessive, excise, expert, exponential, expressly, eye, fatigue, Fc, FcRn, FDIC, FDORA, Florida, fludarabine, forma, Frederick, freely, Gaithersburg, gastrointestinal, gathered, Gilead, gouging, headquartered, hematological, HHS, history, holder, hole, hybrid, IdeXork, immunological, incorrect, Indian, injunction, injunctive, inpatient, insignificant, intangible, intentionally, intermediate, intrinsic, intubation, involuntarily, involuntary, IRA, iterative, Janssen, Johnson, joined, JPMorgan, junction, Justin, Kalayoglu, Kite, Kyverna, Lancet, leasable, legacy, lockup, main, malignancy, manifesting, marked, Maryland, maximize, meaningfully, mechanical, mechanism, mesenchymal, MG, MGC, Michael, Middle, mistakenly, Modernization, molecular, mRNA, MSC, Murat, muscle, musculoskeletal, myasthenia, myeloma, nausea, neonatal, neoplastic, nerve, neurological, Neurology, neurotoxicity, Newer, node, nonexclusive, onset, opposed, Orchard, organizational, outlook, outpatient, outweigh, owner, palliation, paraneoplastic, parent, pari, parity, Parkinsonism, passu, Patrick, Paul, perpetual, pharmacokinetic, plasma, plasmacytoid, play, pocket, possession, pre, proliferate, proliferation, purported, QMG, QoL, qualitative, quantifying, quantitative, quickly, Quince, rank, readout, reallocate, recall, recycling, redemption, regenerative, regularly, relapse, remit, renal, rental, reorganization, repeatedly, replicate, replicated, reprioritization, rescinding, resistant, respiratory, resurgence, retreated, retreatment, risky, RMAT, RNA, RNAC, Road, RP, RRA, runway, Sakura, score, scoring, SE, sentence, sickest, signaling, signatory, Singer, situ, skeletal, SLE, Sloan, Southern, specialist, speech, spontaneously, stability, statutorily, stem, step, strongest, sublessee, subordinated, subsidize, subtherapeutic, surface, surveillance, suspected, SVBB, swallowing, syndrome, tangible, TAS, task, telephonic, thereon, therewith, thrombocytopenic, today, trailing, tranche, trust, UCB, umbilical, unanimously, unaudited, unavailable, unconstrained, undistributed, unilateral, unintentionally, unqualified, ventilation, venture, VIE, vitro, Wymer, York, Zenner
Removed:
Absent, acceleration, accrue, accumulate, accumulation, activation, adult, aged, allantoin, alteration, ameliorating, analogize, analytic, annualized, annum, Anokion, arbitration, attestation, augmentation, Australia, bankruptcy, barrier, batch, Belgium, bench, bifurcation, bile, Brazil, breaking, Brigham, bringing, cardiometabolic, CDER, cellular, characterization, chemical, Children, Chinese, closely, cohort, coli, collaborator, collar, College, combine, commit, compact, COMPARE, compromise, concurrent, condensed, constituent, coordinated, coordination, counterparty, Cour, creditable, custom, CymaBay, damaging, declining, deficient, delivering, depicted, depressing, detract, direction, discourage, disorder, distancing, drawn, dye, economy, effector, Eli, elimination, empty, enabled, endeavor, enhancing, escalating, excrete, excreted, exemption, exhibiting, exploring, exported, expressing, familiar, feasible, fermentation, finalize, flare, floating, fluorescent, fortify, founding, FTCA, genetically, Genfit, glycol, GmbH, GMP, Harvard, Hedging, helper, hematuria, hepatoprotective, hypersensitivity, IGAN, immunogenic, immunogenicity, immunoglobulin, immunomodulating, immunomodulator, immunosuppressive, immunotherapy, immunotolerance, Importantly, improving, incidence, inconvenient, India, induced, induction, inherited, inhibited, inhibition, inhibitory, initiating, injected, injection, insolvency, intact, interrogate, introduced, invite, IP, Japan, jeopardize, Johnston, jointly, journal, JSC, Kei, kidney, Kishimoto, Korea, labeled, learn, lengthen, lesser, lien, lieu, likewise, Linear, liver, Lloyd, location, LogicBio, manuscript, median, Merck, metabolite, Mexico, mice, MIT, MMUT, mode, Moderna, molecule, monthly, mutase, nanoemulsion, nephropathy, neutralize, nonrenewal, nontransferable, North, notable, notably, numerically, observation, older, overproduction, oversee, owe, pain, painful, pairing, patented, PBC, peer, PEG, pegadricase, pegloticase, pegylated, Peter, Pfizer, phenotype, pilot, PLA, pledge, PLGA, POC, polyethylene, portable, Poseida, precise, precisely, preclude, predicted, predisposition, predominantly, premarket, premature, prepay, preserve, prime, principally, proactively, proceed, processed, producing, progression, progressive, prone, prophylactic, put, Rapamune, rapamycin, reacquisition, recalculation, redosing, reducing, redundant, REGiMMUNE, reinstated, rejection, renew, repay, representation, reproducibly, researcher, residual, responder, restore, restoring, restricting, retained, retaliatory, root, ROU, round, running, SA, SAE, safely, Sanofi, scalability, scalable, Scott, SELB, select, separately, separation, shelf, shortage, showed, singular, sixty, skilled, Skolkovo, social, soluble, sourced, sourcing, South, spent, spleen, SQZ, statistical, statistically, steering, stimulation, strategically, strict, strive, subset, Subtopic, suited, susceptibility, symptomatic, systematically, Takashi, tariff, TCJA, team, technically, tolerance, tolerogenic, tophi, Traber, transduced, transplant, Travere, turnover, uncured, undesired, universal, University, unstable, unwanted, uricase, vector, visible, Visterra, vivo, voucher, wage, Wall, warranty, withdrawn, Women, worked
Filing tables
Filing exhibits
Related press release
RNAC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statement (Form S-8, File No. 333-212215) pertaining to the 2008 Stock Incentive Plan, as amended, the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Cartesian Therapeutics, Inc.,
(2)Registration Statement (Form S-8, File No. 333-224109) pertaining to the 2016 Incentive Awards Plan and the 2016 Employee Stock Purchase Plan of Cartesian Therapeutics, Inc.,
(3)Registration Statement (Form S-8, File No. 333-228264) pertaining to the 2018 Employment Inducement Incentive Award Plan of Cartesian Therapeutics, Inc.,
(4)Registration Statement (Form S-8, File No. 333-230501) pertaining to the 2018 Employment Inducement Incentive Award Plan of Cartesian Therapeutics, Inc.,
(5)Registration Statement (Form S-8, File No. 333-239075) pertaining to the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Cartesian Therapeutics, Inc.,
(6)Registration Statement (Form S-8, File No. 333-256061) pertaining to the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Cartesian Therapeutics, Inc.,
(7)Registration Statement (Form S-8, File No. 333-264691) pertaining to the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Cartesian Therapeutics, Inc.,
(8)Registration Statement (Form S-8, File No. 333-274036) pertaining to the 2016 Incentive Award Plan and the 2016 Employee Stock Purchase Plan of Cartesian Therapeutics, Inc.,
(9)Registration Statement (Form S-8, File No. 333-276486) pertaining to the 2016 Stock Incentive Plan and 2018 Employment Inducement Incentive Award Plan of Cartesian Therapeutics, Inc., and
(10)Registration Statement (Form S-3, File No. 333-275171) of Cartesian Therapeutics, Inc.;
of our report dated March 7, 2024 with respect to the consolidated financial statements of Cartesian Therapeutics, Inc. included in this Annual Report (Form 10-K) of Cartesian Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 7, 2024